Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer

PURPOSE: To monitor the outcomes for intermediate-risk prostate cancer patients treated with biologically effective dose (BED) ≥ 200 Gy radiotherapy using low-dose-rate (LDR) brachytherapy. MATERIAL AND METHODS: Between 2005 and 2016, a total of 397 patients with intermediate-risk prostate cancer we...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Keisei, Okuyama, Kahori, Kohno, Naoaki, Tsugawa, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073334/
https://www.ncbi.nlm.nih.gov/pubmed/32190064
http://dx.doi.org/10.5114/jcb.2020.92405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073334/
https://www.ncbi.nlm.nih.gov/pubmed/32190064
http://dx.doi.org/10.5114/jcb.2020.92405

Ejemplares similares